Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Silvio Caccia, Antonio Clavenna & Maurizio Bonati. (2011) Antipsychotic drug toxicology in children. Expert Opinion on Drug Metabolism & Toxicology 7:5, pages 591-608.
Read now
Read now
Suad Kapetanovic, Lisa Aaron, Paige L Williams, John Farley, Patricia A Sirois, Patricia A Garvie, Deborah A Pearson, James M Oleske & Grace Montepiedra. (2010) Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV. Neurobehavioral HIV Medicine 2, pages 39-48.
Read now
Read now
Garry Walter, Amy Delaroche, Nerissa Soh, Glenn Hunt, Michelle Cleary, Gin Malhi, Tim Lambert, Christoph Correll & Joseph Rey. (2008) Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Australasian Psychiatry 16:4, pages 253-262.
Read now
Read now
Maria Deurell, Merete Weischer, Anne Katrine Pagsberg & Jette Labianca. (2008) The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey. Nordic Journal of Psychiatry 62:6, pages 472-480.
Read now
Read now
Articles from other publishers (12)
Jeffrey B. Russ, Akila M. Nallappan & Amy Robichaux-Viehoever. (2018) Management of Pediatric Movement Disorders: Present and Future. Seminars in Pediatric Neurology 25, pages 136-151.
Crossref
Crossref
Su Xu, Rao P. Gullapalli & Douglas O. Frost. (2015) Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens. Schizophrenia Research 161:2-3, pages 452-457.
Crossref
Crossref
Tanya EbertYael MidbariRonen ShmilovitzIra KosovMoshe KotlerAbraham WeizmanAnca Ram. (2014) Metabolic Effects of Antipsychotics in Prepubertal Children: A Retrospective Chart Review. Journal of Child and Adolescent Psychopharmacology 24:4, pages 218-222.
Crossref
Crossref
Silvio Caccia. (2013) Safety and Pharmacokinetics of Atypical Antipsychotics in Children and Adolescents. Pediatric Drugs 15:3, pages 217-233.
Crossref
Crossref
Antonio Clavenna, Margherita Andretta, Paola Pilati, Maurizio Dusi, Michele Gangemi, Maria Beatrice Gattoni, Giuseppe Lombardo, Leonardo Zoccante, Luigi Mezzalira & Maurizio Bonati. (2011) Antidepressant and antipsychotic use in an Italian pediatric population. BMC Pediatrics 11:1.
Crossref
Crossref
M. de Hert, M. Dobbelaere, E.M. Sheridan, D. Cohen & C.U. Correll. (2011) Efectos adversos metabólicos y endocrinos de los antipsicóticos de segunda generación en niños y adolescentes: una revisión sistemática de ensayos aleatorizados, controlados con placebo y guías de práctica clínica. Psiquiatría Biológica 18:3, pages 89-104.
Crossref
Crossref
M. De Hert, M. Dobbelaere, E.M. Sheridan, D. Cohen & C.U. Correll. (2020) Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European Psychiatry 26:3, pages 144-158.
Crossref
Crossref
Suad KapetanovicLisa AaronGrace MontepiedraPatricia A. SiroisJames M. OleskeKathleen MaleeDeborah A. PearsonSharon L. NicholsPatricia A. GarvieJohn FarleyMolly L. NozyceMark MintzPaige L. Williams. (2009) The Use of Second-Generation Antipsychotics and the Changes in Physical Growth in Children and Adolescents with Perinatally Acquired HIV. AIDS Patient Care and STDs 23:11, pages 939-947.
Crossref
Crossref
Patricia A. Sirois, Grace Montepiedra, Suad Kapetanovic, Paige L. Williams, Deborah A. Pearson, Kathleen Malee, Patricia A. Garvie, Betsy L. Kammerer, Sharon L. Nichols, Molly L. Nozyce, Mark Mintz, Wendy G. Mitchell & James M. Oleske. (2009) Impact of Medications Prescribed for Treatment of Attention-Deficit Hyperactivity Disorder on Physical Growth in Children and Adolescents With HIV. Journal of Developmental & Behavioral Pediatrics 30:5, pages 403-412.
Crossref
Crossref
Johnny L. Matson & Daniene Neal. (2009) Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview. Research in Developmental Disabilities 30:3, pages 572-586.
Crossref
Crossref
David Fraguas, Cloe Llorente, Marta Rapado-Castro, Mara Parellada, Dolores Moreno, Ana Ruiz-Sancho, Óscar Medina, Mar Álvarez-Segura, María J. de Castro & Celso Arango. (2008) Actitud respecto a la medicación antipsicótica como factor predictivo de la suspensión del tratamiento antipsicótico en el período inicial de la psicosis de inicio temprano. Revista de Psiquiatría y Salud Mental 1:1, pages 10-17.
Crossref
Crossref
David Fraguas, Cloe Llorente, Marta Rapado-Castro, Mara Parellada, Dolores Moreno, Ana Ruiz-Sancho, Óscar Medina, Mar Álvarez-Segura, María J. de Castro & Celso Arango. (2008) Attitude Toward Antipsychotic Medication as a Predictor of Antipsychotic Treatment Discontinuation in First-Episode Early-Onset Psychosis. Revista de Psiquiatría y Salud Mental (English Edition) 1:1, pages 10-17.
Crossref
Crossref